Lataa...
Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies
Reducing delays related to inpatient chemotherapy may reduce healthcare costs. Using a national database, we identified patients with lymphoma/leukemia with ≥1 etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone (EPOCH) chemotherapy claim and evaluated chemotherapy initiation delay...
Tallennettuna:
| Julkaisussa: | Cancer Invest |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700415/ https://ncbi.nlm.nih.gov/pubmed/28165774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07357907.2016.1276186 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|